Today Leerink Swann Reconfirms a “Buy” Rating on CVS Health (NYSE:CVS) and a $85.0 Target Price
February 11, 2018 - By Winifred Garcia Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It dropped, as 60 investors sold CVS Health ...